ACADIA Pharmaceuticals Cash Flow Statement
NASDAQ: ACADHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ACADIA Pharmaceuticals free cash flow
In fiscal 2025, ACADIA Pharmaceuticals generated $109.8 million of operating cash flow and spent $4.7 million on capital expenditures. That left free cash flow of $105.1 million, a free-cash-flow margin of 9.8% of revenue. Free cash flow was down 33.1% from the prior year's $157.2 million.
Summary generated from market data by MetaCap's automated system. Methodology
ACADIA Pharmaceuticals cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 391.00M | 226.45M | -61.29M | -215.97M | -167.87M | -281.58M | -235.26M | -245.19M | -289.40M | -271.39M |
| Net Income growth (YoY) | +72.66% | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 871.00K | 920.00K | 1.46M | 2.03M | 2.24M | 1.46M | 1.29M | 1.53M | 1.24M | 843.00K |
| Stock-Based Compensation | 52.13M | 67.05M | 66.42M | 68.20M | 63.62M | 84.42M | 82.27M | 81.56M | 75.53M | 55.27M |
| Change in Working Capital | -47.98M | -48.35M | -54.04M | 12.45M | -20.08M | -12.01M | -5.84M | -11.31M | -9.76M | -4.86M |
| Operating Cash Flow | 109.84M | 157.72M | 16.70M | -114.03M | -125.66M | -136.17M | -151.13M | -167.47M | -217.76M | -208.41M |
| Capital Expenditures | -4.69M | -523.00K | -50.00K | 0 | -1.12M | -7.59M | -1.13M | -2.10M | -812.00K | -1.51M |
| Investing Cash Flow | -302.56M | -30.54M | 32.00M | 73.24M | -71.10M | 192.51M | -165.84M | -71.49M | 92.47M | -261.92M |
| Financing Cash Flow | 49.88M | 6.84M | 25.13M | 8.20M | 18.16M | 81.00M | 371.85M | 306.65M | 31.19M | 533.81M |
| Net Change in Cash | -142.82M | 133.93M | 73.81M | -32.59M | -178.59M | 137.33M | 54.88M | 67.69M | -94.10M | 63.48M |
| Free Cash Flow | 105.15M | 157.20M | 16.65M | -114.03M | -126.78M | -143.75M | -152.26M | -169.57M | -218.57M | -209.91M |
This table shows 10 annual periods of ACADIA Pharmaceuticals's cash flow statement, from FY 2025 back to FY 2016, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ACAD's reporting calendar. What is a cash flow statement?